In our study, we established a clinical link between p-ERK1/2 expression and poor prognosis in DLBCL, and identified a significant positive correlation between CCR7 and p-ERK1/2 expression in DLBCL tissue samples. Here, CCR7 is linked to diffuse large B-cell lymphoma.